(E)-2-(3-(2-chloro-6-methoxyquinolin-3-yl)acrylamido)cyclohex-1-enecarboxylic acid

ID: ALA3299112

Chembl Id: CHEMBL3299112

PubChem CID: 90645409

Max Phase: Preclinical

Molecular Formula: C20H19ClN2O4

Molecular Weight: 386.84

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc2nc(Cl)c(/C=C/C(=O)NC3=C(C(=O)O)CCCC3)cc2c1

Standard InChI:  InChI=1S/C20H19ClN2O4/c1-27-14-7-8-16-13(11-14)10-12(19(21)23-16)6-9-18(24)22-17-5-3-2-4-15(17)20(25)26/h6-11H,2-5H2,1H3,(H,22,24)(H,25,26)/b9-6+

Standard InChI Key:  RVNOSWCZAUWJNI-RMKNXTFCSA-N

Associated Targets(Human)

HCAR1 Tchem G-protein coupled receptor 81 (382 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCAR2 Tclin Hydroxycarboxylic acid receptor 2 (1903 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCAR3 Tchem HM74 nicotinic acid GPCR (353 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 386.84Molecular Weight (Monoisotopic): 386.1033AlogP: 3.94#Rotatable Bonds: 5
Polar Surface Area: 88.52Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.07CX Basic pKa: 0.46CX LogP: 3.28CX LogD: -0.19
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.60Np Likeness Score: -0.46

References

1. Bobileva O, Bokaldere R, Gailite V, Kaula I, Ikaunieks M, Duburs G, Petrovska R, Mandrika I, Klovins J, Loza E..  (2014)  Synthesis and evaluation of (E)-2-(acrylamido)cyclohex-1-enecarboxylic acid derivatives as HCA1, HCA2, and HCA3 receptor agonists.,  22  (14): [PMID:24864041] [10.1016/j.bmc.2014.05.011]

Source